Oxygen free radicals in interleukin-1beta-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients - PubMed (original) (raw)
Oxygen free radicals in interleukin-1beta-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients
R Lu et al. Thyroid. 1999 Mar.
Abstract
Graves' ophthalmopathy (GO) is attributed to an autoimmune process that results in the accumulation in retro-ocular tissue of glycosaminoglycans (GAG) that are in turn responsible for the development of clinical signs and symptoms. Retro-ocular fibroblasts are thought to be the source of GAG production and deposition in GO. In the present study, we investigated interleukin (IL)-1beta-induced oxygen free radical production and the role of oxygen free radicals in IL-1beta-induced GAG production in retro-ocular fibroblasts from both normal subjects and patients with GO. Normal retro-ocular fibroblasts demonstrated no measurable oxygen free radicals whereas GO retro-ocular fibroblasts showed detectable signals by electron paramagnetic resonance (EPR) spectroscopy. IL-1beta increased the free radical production in both cells. Superoxide dismutase (SOD) activity in GO retroocular fibroblasts was higher than that in normal cells. IL-1beta dose- and time-dependently stimulated the SOD activity in both cells, with GO retro-ocular fibroblasts showing less responsiveness. IL-1beta dose-dependently increased [3H]glucosamine incorporation into GAG by both cells. An exogenous oxygen free radical-generating system failed to increase GAG. Scavenging oxygen free radicals by the use of SOD (100 U/mL) and catalase (300 U/mL) partially blocked the IL-1beta-induced GAG production in both cells. These results suggest that stress related oxygen free radicals are present in the retro-ocular tissue in GO and that oxygen free radicals are involved in GAG accumulation induced by cytokine IL-1beta.
Similar articles
- Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy.
Burch HB, Lahiri S, Bahn RS, Barnes S. Burch HB, et al. Exp Eye Res. 1997 Aug;65(2):311-6. doi: 10.1006/exer.1997.0353. Exp Eye Res. 1997. PMID: 9268599 - Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts.
Korducki JM, Loftus SJ, Bahn RS. Korducki JM, et al. Invest Ophthalmol Vis Sci. 1992 May;33(6):2037-42. Invest Ophthalmol Vis Sci. 1992. PMID: 1582808 - Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications.
Bartalena L, Tanda ML, Piantanida E, Lai A. Bartalena L, et al. Biofactors. 2003;19(3-4):155-63. doi: 10.1002/biof.5520190308. Biofactors. 2003. PMID: 14757966 Review. - Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy.
Bahn RS, Heufelder AE. Bahn RS, et al. Thyroid. 1992 Spring;2(1):89-94. doi: 10.1089/thy.1992.2.89. Thyroid. 1992. PMID: 1525575 Review.
Cited by
- Efficacy of selenium supplementation for mild-to-moderate Graves' ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial.
Chung CW, Jung KY, Jung EH, Lee MJ, Park YJ, Lee JK, Ahn HY, Cho SW. Chung CW, et al. Trials. 2023 Apr 14;24(1):272. doi: 10.1186/s13063-023-07282-4. Trials. 2023. PMID: 37060084 Free PMC article. - A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.
Kemchoknatee P, Tangon D, Srisombut T. Kemchoknatee P, et al. BMC Ophthalmol. 2023 Jan 23;23(1):32. doi: 10.1186/s12886-023-02789-5. BMC Ophthalmol. 2023. PMID: 36690985 Free PMC article. - Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves' Orbitopathy.
Ma C, Li H, Liu W, Lu S, Li X, Chen J, Li K, Wang W. Ma C, et al. J Immunol Res. 2022 Sep 15;2022:4432584. doi: 10.1155/2022/4432584. eCollection 2022. J Immunol Res. 2022. PMID: 36157877 Free PMC article. - Research progress on the pathogenesis of Graves' ophthalmopathy: Based on immunity, noncoding RNA and exosomes.
Zheng J, Duan H, You S, Liang B, Chen Y, Huang H. Zheng J, et al. Front Immunol. 2022 Aug 23;13:952954. doi: 10.3389/fimmu.2022.952954. eCollection 2022. Front Immunol. 2022. PMID: 36081502 Free PMC article. Review. - A Systematic Review on the Role of Antioxidants in Thyroid Eye Disease.
Akbarian S, Chaibakhsh S, Kashkouli MB, Karimi N, Abdolalizadeh P, Ghahvehchian H. Akbarian S, et al. J Curr Ophthalmol. 2022 Apr 16;34(1):16-24. doi: 10.4103/joco.joco_266_21. eCollection 2022 Jan-Mar. J Curr Ophthalmol. 2022. PMID: 35620378 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources